Delivery Order SPE2DR25D2010-SPE2DR26F4ZNK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of January 22, 2026. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on January 2, 2026, with a completion date of January 26, 2026. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order...
- The Defense Logistics Agency awarded a delivery order valued at $12,994.64 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of December 23, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Defense Health Agency and...
- The Defense Logistics Agency has awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector units, with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector, with an ultimate completion date of September 3, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters operations as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on December 29, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of January 21, 2026. The award is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Benlysta 200 mg/ml auto-injector pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of January 5, 2026, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, leveraging its...
- The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Benlysta 200 mg/mL auto-injectors. This non-set-aside, competitively awarded contract reflects firm fixed pricing and is scheduled for completion by January 20, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at the same address. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 10, 2025, with an ultimate completion date of October 1, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $3,486.67 firm fixed price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical products, with a completion date of January 27, 2026. The award was made on January 5, 2026, with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the place of performance for this order—is a major pharmaceutical distributor serving federal...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZNKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of January 28, 2026. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and was executed on January 6, 2026. The awardee will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order is issued under Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2031. This primary vehicle enables comprehensive global pharmaceutical support to military healthcare systems and covers a diverse range of medical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract supports critical federal healthcare initiatives including the Defense Health Agency, U.S. Coast Guard, and military treatment facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 1/5/26 |